| Trial ID: | L1567 |
| Source ID: | NCT00849316
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Chronic Kidney Disease
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Incidence of major hypoglycaemic episodes, during 26 weeks | Secondary: Number of serious adverse events, during 26 weeks|Number of serious adverse drug reactions, during 26 weeks|Number of all daytime and nocturnal major hypoglycaemic events, during 26 weeks|Number of major hypoglycaemic events related to omission of a meal after injection, during 26 weeks|Number of all minor (daytime and nocturnal) hypoglycaemic events, during 4 weeks proceeding each study visits during Insulin Aspart (NovoRapidTM) therapy
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-02
|
| Completion Date: |
2009-11
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00849316
|
